Literature DB >> 8356081

Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.

Y Pak1, C R Paule, Y D Bao, L C Huang, J Larner.   

Abstract

HIRc-B cells (rat fibroblasts expressing the human insulin receptor) were incubated with myo-[3H]inositol for 48 hr, and the biosynthesis of chiro-[3H]inositol was investigated in the absence and presence of insulin following a time course up to 60 min. After phase separation, treatment with insulin for 15 min caused a 2.2-fold increase in the specific radioactivity of chiro-[3H]inositol-containing phospholipids in contrast to a 1.2-fold increase in the specific radioactivity of myo-[3H]inositol-containing phospholipids. No insulin-mediated change in the specific radioactivity was observed in the inositol phosphates or free inositols. Further detailed analysis of individual [3H]inositol-containing phospholipids demonstrated marked increases in specific activity of the chiro-[3H]inositol phospholipids after 15 min of incubation with insulin: phosphatidylinositol 4-phosphate and 4,5-bisphosphate, 4.2-fold; lysophosphatidylinositol, 1.5-fold; phosphatidylinositol, 3.2-fold. In contrast, myo-[3H]inositol-containing phospholipids demonstrated relatively small increases (1.1- to 1.4-fold) after 5 min of incubation with insulin. These findings indicate that insulin stimulates de novo synthesis of chiro-inositol-containing phospholipids at the inositol phospholipid level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356081      PMCID: PMC47222          DOI: 10.1073/pnas.90.16.7759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Lipid-derived mediators in insulin action.

Authors:  R V Farese
Journal:  Proc Soc Exp Biol Med       Date:  1990-12

2.  Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation.

Authors:  J Larner; G Galasko; K Cheng; A A DePaoli-Roach; L Huang; P Daggy; J Kellogg
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

3.  Identification and characterization of chiroinositol-containing phospholipids from bovine liver.

Authors:  Y Pak; J Larner
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

4.  Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle.

Authors:  L Jarett; J R Seals
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

5.  Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid.

Authors:  A R Saltiel; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.

Authors:  Y Pak; L C Huang; K J Lilley; J Larner
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

7.  The de novo phospholipid effect of insulin is associated with increases in diacylglycerol, but not inositol phosphates or cytosolic Ca2+.

Authors:  R V Farese; J S Davis; D E Barnes; M L Standaert; J S Babischkin; R Hock; N K Rosic; R J Pollet
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

8.  Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.

Authors:  H K Ortmeyer; N L Bodkin; K Lilley; J Larner; B C Hansen
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

9.  Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

Authors:  A S Kennington; C R Hill; J Craig; C Bogardus; I Raz; H K Ortmeyer; B C Hansen; G Romero; J Larner
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

Review 10.  Insulin mediators and the mechanism of insulin action.

Authors:  G Romero; J Larner
Journal:  Adv Pharmacol       Date:  1993
View more
  5 in total

1.  Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.

Authors:  Jean-Patrice Baillargeon; Maria J Iuorno; Teimuraz Apridonidze; John E Nestler
Journal:  Metab Syndr Relat Disord       Date:  2010-04       Impact factor: 1.894

2.  Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.

Authors:  Tae-Sik Jung; Jong-Ryeal Hahm; Jong-Jin Kim; Jung-Hwa Jung; Mi-Yeon Kang; Sung-Won Moon; Kang-Wan Lee; Ho-Cheol Kim; Jong-Deog Lee; Ji-Hye Kim; Deok-Ryong Kim; Soon-Il Chung
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

3.  Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.

Authors:  Jean-Patrice Baillargeon; John E Nestler; Richard E Ostlund; Teimuraz Apridonidze; Evanthia Diamanti-Kandarakis
Journal:  Hum Reprod       Date:  2008-03-29       Impact factor: 6.918

4.  A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2.

Authors:  Hayeong Kwon; Kyuho Jeong; Eun Mi Hwang; Jae-Yong Park; Yunbae Pak
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

5.  Insulin-response epigenetic activation of Egr-1 and JunB genes at the nuclear periphery by A-type lamin-associated pY19-Caveolin-2 in the inner nuclear membrane.

Authors:  Kyuho Jeong; Hayeong Kwon; Jaewoong Lee; Donghwan Jang; Yunbae Pak
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.